Comic: Stock market weighs spike in COVID-19 cases, vaccine progress


By Jesse Cohen – Wall Street shares ended lower on Friday as investors weighed in on the worrying increase in the news

Covid-19 case

against the apparent progress on



The decline of 219 points, or 0.8%, ended the day at 29,263. The 0.7% discount to settle at 3,557, while the end of the session fell 0.4% to 11,854 .

For the week, the Dow and the S&P 500 lost 0.7% and 0.8% respectively to post their first weekly decline in three weeks. The techie, however, managed to get a gain of 0.2% over this period.

Coronavirus cases are skyrocketing in the United States, leading a handful of states and cities to reimpose social distancing restrictions to try to slow the rapid spread of the disease ahead of the winter season.

Public health professionals are also urging people to ditch holiday gatherings, days away from Thanksgiving.

The biggest question in the market right now is whether the negative headlines from the surging virus cases and new lockdowns will be enough to derail the positive developments seen on the vaccine front.

Good news about potential vaccines for Pfizer (NYSE 🙂 and Moderna (NASDAQ 🙂 had helped push the Dow and the S&P 500 to an all-time high earlier in the week.


Please enter your comment!
Please enter your name here